Time to rethink aspirin in diabetes?

BMJ (Online)

Volumn 339, Issue 7736, 2009, Pages 8-

  Song, Soon H ^a   Gray, Trevor A ^a   Tesfaye, Solomon ^b  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIDIABETIC AGENT;

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; HUMAN; LETTER; LIFESTYLE MODIFICATION; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; UNITED KINGDOM; VASCULAR DISEASE; DIABETIC ANGIOPATHY; NOTE;

ASPIRIN; DIABETIC ANGIOPATHIES; HUMANS; HYPOGLYCEMIC AGENTS;

EID: 84879251869     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b5588     Document Type: Letter

References (5)

1. De Berardis G, Sacco M, Strippoli GFM, Pellegrini F, Graziano G, Tognoni G, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ 2009;339:b4531. (6 November.)[Abstract/Free Full Text]
2. Antithrombotic Trialists' Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849-60.[CrossRef][Web of Science][Medline]
3. Calvin AD, Aggarwal NR, Murad MH, Shi Q, Elamin MB, Geske JB, et al. Aspirin for primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes. Diabetes Care 2009 Sep 9 [Epub ahead of print].
4. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329:15-9. [Abstract/Free Full Text]
5. Diabetes UK. Aspirin treatment in diabetes. Care recommendations. www.diabetes.org.uk (accessed 12 Nov 2009).